NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
The innovation is particularly suited for bone and cartilage repair
The innovation is particularly suited for bone and cartilage repair
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Subscribe To Our Newsletter & Stay Updated